Belumosudil
Idiopathic Pulmonary Fibrosis
Clinical trials
2
Developer
Kadmon Corporation, LLC
Overview
Belumosudil is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.
Belumosudil clinical trials
Explore related
Medical disclaimer. This page summarizes research about Belumosudil for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.